Stock 533212 GKB OPHTHALMICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials GKB Ophthalmics Limited

Equities

533212

INE265D01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E.
Other stock markets
 06:00:58 2024-06-14 am EDT 		5-day change 1st Jan Change
95.84 INR -0.98% Intraday chart for GKB Ophthalmics Limited +5.52% -4.22%
May. 30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Mar. 19 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 481.8 429.5 216.7 413.3 463.7 547.2
Enterprise Value (EV) 1 555.8 476.8 236.6 363.7 423.1 518.2
P/E ratio -49.6 x -38.9 x -11.8 x -45.5 x 36.4 x -327 x
Yield - - - - - -
Capitalization / Revenue 0.62 x 0.75 x 0.37 x 0.73 x 0.65 x 0.72 x
EV / Revenue 0.72 x 0.83 x 0.4 x 0.64 x 0.6 x 0.69 x
EV / EBITDA 41.6 x 28.2 x 10 x 15.3 x 8.55 x 14.1 x
EV / FCF -11.7 x -5.03 x -6.6 x -38.7 x -25.6 x -8.45 x
FCF Yield -8.51% -19.9% -15.2% -2.58% -3.9% -11.8%
Price to Book 1.07 x 0.78 x 0.37 x 0.66 x 0.73 x 0.87 x
Nbr of stocks (in thousands) 4,154 4,641 5,041 5,041 5,041 5,041
Reference price 2 116.0 92.55 43.00 82.00 92.00 108.6
Announcement Date 7/27/18 8/31/19 9/4/20 9/3/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 774.2 574.1 585.3 568.8 709.4 754.7
EBITDA 1 13.37 16.9 23.57 23.83 49.52 36.83
EBIT 1 -3.302 -18.39 -12.57 -7.568 22.85 8.561
Operating Margin -0.43% -3.2% -2.15% -1.33% 3.22% 1.13%
Earnings before Tax (EBT) 1 -11.36 -15.79 -18.4 -9.285 19.46 1.394
Net income 1 -9.707 -11.04 -18.4 -9.075 12.74 -1.674
Net margin -1.25% -1.92% -3.14% -1.6% 1.8% -0.22%
EPS 2 -2.337 -2.379 -3.650 -1.800 2.528 -0.3321
Free Cash Flow 1 -47.3 -94.76 -35.85 -9.392 -16.5 -61.32
FCF margin -6.11% -16.5% -6.12% -1.65% -2.33% -8.12%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/27/18 8/31/19 9/4/20 9/3/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 74 47.3 19.9 - - -
Net Cash position 1 - - - 49.6 40.6 29
Leverage (Debt/EBITDA) 5.532 x 2.8 x 0.8426 x - - -
Free Cash Flow 1 -47.3 -94.8 -35.8 -9.39 -16.5 -61.3
ROE (net income / shareholders' equity) -2.12% -2.21% -3.23% -1.19% 2.91% 0.17%
ROA (Net income/ Total Assets) -0.25% -1.3% -0.8% -0.45% 1.32% 0.48%
Assets 1 3,875 847.5 2,291 2,006 968 -348
Book Value Per Share 2 108.0 118.0 118.0 124.0 125.0 124.0
Cash Flow per Share 2 5.220 20.10 26.10 11.90 11.70 4.690
Capex 1 18.8 132 38.6 63.3 47.6 16.6
Capex / Sales 2.42% 22.98% 6.6% 11.13% 6.71% 2.2%
Announcement Date 7/27/18 8/31/19 9/4/20 9/3/21 9/7/22 8/22/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
GKB OPHTHALMICS LIMITED Stock GKB Ophthalmics Limited
-4.22% 5.78M
ESSILORLUXOTTICA Stock EssilorLuxottica
+10.68% 97.93B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-1.20% 18.61B
AUTEK CHINA INC. Stock Autek China Inc.
-22.59% 2.16B
WARBY PARKER INC. Stock Warby Parker Inc.
+14.96% 1.93B
PEGAVISION CORPORATION Stock Pegavision Corporation
+17.53% 1.12B
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-9.75% 654M
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-44.15% 647M
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+65.72% 641M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-46.38% 614M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 533212 Stock
  4. Financials GKB Ophthalmics Limited